Advertisement

Research Article Free access | 10.1172/JCI3145

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

D A Arenberg, M P Keane, B DiGiovine, S L Kunkel, S B Morris, Y Y Xue, M D Burdick, M C Glass, M D Iannettoni, and R M Strieter

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Arenberg, D. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Keane, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by DiGiovine, B. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Kunkel, S. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Morris, S. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Xue, Y. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Burdick, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Glass, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Iannettoni, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642, USA.

Find articles by Strieter, R. in: JCI | PubMed | Google Scholar

Published August 1, 1998 - More info

Published in Volume 102, Issue 3 on August 1, 1998
J Clin Invest. 1998;102(3):465–472. https://doi.org/10.1172/JCI3145.
© 1998 The American Society for Clinical Investigation
Published August 1, 1998 - Version history
View PDF
Abstract

We report here the role of the CXC chemokine, epithelial neutrophil activating peptide (ENA-78), as an angiogenic factor in human non-small cell lung cancer (NSCLC). In freshly isolated human specimens of NSCLC, elevated levels of ENA-78 were found that strongly correlated with the vascularity of the tumors. In a SCID mouse model of human NSCLC tumorigenesis, expression of ENA-78 in developing tumors correlated with tumor growth in two different NSCLC cell lines. Furthermore, passive immunization of NSCLC tumor-bearing mice with neutralizing anti-ENA-78 antibodies reduced tumor growth, tumor vascularity, and spontaneous metastases, while having no effect on the proliferation of NSCLC cells either in vitro or in vivo. These findings suggest that ENA-78 is an important angiogenic factor in human NSCLC.

Version history
  • Version 1 (August 1, 1998): No description
Advertisement
Advertisement